Alexander Nowak
Stock Analyst at Craig-Hallum
(2.71)
# 1,867
Out of 5,127 analysts
46
Total ratings
45.95%
Success rate
7.07%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Maintains: Buy | $96 → $108 | $107.90 | +0.09% | 3 | Nov 13, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $6.56 | +235.37% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $210.58 | -25.44% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $8.52 | +99.53% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $29.26 | +94.81% | 6 | Sep 5, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $20.19 | -25.71% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $8.15 | -1.84% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $1.55 | +1,061.29% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $18.89 | +164.69% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $280 → $160 | $10.42 | +1,435.51% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $103.32 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.81 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.12 | +418.87% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $65.48 | +67.99% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $8.04 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $1.69 | +17,651.48% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $7.66 | +265.54% | 1 | Aug 31, 2020 |
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $96 → $108
Current: $107.90
Upside: +0.09%
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $6.56
Upside: +235.37%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $210.58
Upside: -25.44%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $8.52
Upside: +99.53%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $29.26
Upside: +94.81%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $20.19
Upside: -25.71%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $8.15
Upside: -1.84%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $1.55
Upside: +1,061.29%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $18.89
Upside: +164.69%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280 → $160
Current: $10.42
Upside: +1,435.51%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $103.32
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.81
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.12
Upside: +418.87%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $65.48
Upside: +67.99%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $8.04
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $1.69
Upside: +17,651.48%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $7.66
Upside: +265.54%